SCHEMBL8430809

SCHEMBL8430809

NN=CNc1cccc([C@@](C(=O)O)(C(=C=O)c2ccccc2)N(N)S(=O)(=O)c2cc(Cl)cc(Cl)c2)c1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA4 P22748 2/20 0.32
KMT2A Q03164 4/20 0.32
MAPT P10636 4/20 0.32
MEN1 O00255 3/20 0.32
ALDH1A1 P00352 3/20 0.32
LMNA P02545 3/20 0.32
HTT P42858 2/20 0.32
ACLY P53396 1/20 0.31
PGR P06401 1/20 0.31
IDH2 P48735 1/20 0.31
GAA P10253 1/20 0.30
THRB P10828 1/20 0.30
DAGLA Q9Y4D2 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
S1PR1 P21453 1/20 0.30
CTSL P07711 1/20 0.30
CTSS P25774 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8430880 0.92 CA1 (0.37) CA1CA2CA4KMT2AMEN1
SCHEMBL8429290 0.85 CA1 (0.33) CA1CA2CA4KMT2AMAPT
SCHEMBL8429052 0.81 PPARG (0.34) CA1CA2CA4KMT2A
SCHEMBL8431435 0.81 CA1 (0.32) CA1CA2CA4KMT2AMAPT
SCHEMBL8430856 0.80 CA1 (0.37) CA1CA2CA4KMT2AMAPT
SCHEMBL8431176 0.80 UBE2M (0.34) CA1CA2CA4ALDH1A1HTT
SCHEMBL8432441 0.79 KMT2A (0.32) CA1CA2CA4KMT2AMEN1
SCHEMBL8431235 0.79 RXFP1 (0.32) CA1CA2CA4KMT2AMAPT
SCHEMBL8429055 0.78 TRPV4 (0.35) CA1CA2CA4KMT2AMAPT
SCHEMBL8430969 0.77 NR1H4 (0.33) KMT2AMAPTMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952381-A SELECTIVELY INHIBITING OR ANTAGONIZING THE INTEGRINS; ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS, VIRICIDES, MICROBIOCIDES; TREATING OSTEOPOROSIS, SKIN DISORDERS G. D. SEARLE & CO. (US) 1999-09-14 US disclosed